Guidelines for Interpretation of Bronchoalveolar Lavage (BAL) Cellular Differentials

Normal Reference Ranges in Healthy Never‑Smokers

In individuals who have never smoked, alveolar macrophages normally comprise 85–95 % of BAL cells【1】【3】【4】.
Lymphocytes normally account for 3–15 % (mean ≈ 6–12 %) of BAL cells【1】【2】【3】.
Neutrophils are typically < 3 % (mean ≈ 0.5–2 %) of BAL cells【1】【2】【3】.
Eosinophils are usually < 1 % (mean ≈ 0.1–0.5 %) of BAL cells【1】【2】【3】.
Mast cells are generally < 0.5 % of BAL cells【1】【2】.

Current smokers show a markedly higher total cell count (≈ 418 × 10³ cells /ml vs ≈ 129 × 10³ cells /ml in never‑smokers)【3】【4】.
In smokers, the proportion of macrophages rises to ≈ 92.5 %, while lymphocytes fall to ≈ 5.2 %【3】【4】.

Lymphocytes > 15 %, neutrophils > 3 %, eosinophils > 1 %, or mast cells > 0.5 % are considered abnormal and suggest specific interstitial lung diseases【1】【2】.

25–50 % lymphocytes point toward granulomatous disorders (e.g., sarcoidosis, hypersensitivity pneumonitis), chronic beryllium disease, drug reactions, lymphocytic interstitial pneumonia, cryptogenic organizing pneumonia, or lymphoma【1】【4】【6】.
> 50 % lymphocytes are especially indicative of hypersensitivity pneumonitis or cellular nonspecific interstitial pneumonia【1】【4】【6】.
When > 50 % lymphocytes coexist with > 3 % neutrophils and > 1 % mast cells, the pattern is highly specific for hypersensitivity pneumonitis【3】【4】【6】.

≥ 50 % neutrophils strongly support acute lung injury, aspiration pneumonia, or suppurative infection (infection must first be ruled out)【3】【4】【6】.
Moderate neutrophilia (3–50 %) may be seen in idiopathic pulmonary fibrosis, acute interstitial pneumonia, or connective‑tissue‑disease‑associated ILD【1】【4】.

An eosinophil proportion > 1 % suggests eosinophilic pneumonia or drug‑induced lung disease【1】【4】【6】.
Marked eosinophilia further strengthens these diagnoses when the clinical context aligns【1】.

Predominance of hemosiderin‑laden macrophages indicates chronic or occult alveolar hemorrhage syndromes, pulmonary hemosiderosis, or diffuse alveolar damage【3】【4】【6】.
Predominant macrophages with smoking‑related inclusions (and minimal elevation of other cells) are compatible with smoking‑related ILD such as desquamative interstitial pneumonia, respiratory bronchiolitis‑ILD, or pulmonary Langerhans cell histiocytosis【3】【4】【7】.

Retrieved volume ≥ 30 % of the instilled saline volume is required for reliable distal airway sampling【8】【9】【7】.
Detection of squamous epithelial cells signals upper‑airway contamination, rendering the specimen potentially unreliable【1】【2】【5】.
Large numbers of bronchial epithelial cells indicate inadequate distal sampling【1】【2】【5】.
A minimum 400 cells must be counted for differential analysis using cytocentrifugation with Wright‑Giemsa or May‑Grünwald‑Giemsa stains【2】【5】【10】.
Processing timeline: BAL fluid should be analyzed within 1 hour if stored in saline, or within 2–3 hours if placed in nutrient‑supplemented medium【5】【10】.

BAL results must not be interpreted in isolation; they should be correlated with clinical presentation, high‑resolution CT imaging, and exclusion of infection【1】【9】.
Mixed cellular patterns can occur across ILDs; the dominant cell type generally guides the most likely diagnosis【1】【2】.
A normal BAL differential does not exclude microscopic lung pathology; tissue biopsy may still be required when suspicion persists【8】【9】.
Infection exclusion is mandatory; excess BAL fluid should be cultured for mycobacteria and fungi before attributing cellular patterns to ILD【1】【2】【5】.